Primary HIV infection. Current trends in transmission, testing, and treatment

Postgraduate Medicine

Volumn 107, Issue 4, 2000, Pages 114-122

  Yu, Kalvin ^a   Daar, Eric S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

CONFERENCE PAPER; DISEASE TRANSMISSION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNE SYSTEM; INFECTION RISK; PRIMARY INFECTION; SYMPTOMATOLOGY;

EID: 0034004888     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.2000.04.984     Document Type: Conference Paper

References (20)

1. Daar ES. Virology and immunology of acute HIV type 1 infection. AIDS Res Human Retroviruses 1998;14(Suppl 3):S229-34
2. Vanhems P, Allard R, Cooper DA, et al. Acute human immunodeficiency virus type 1 disease as a mononucleosis-like illness: is the diagnosis too restrictive? Clin Infect Dis 1997;24(5):965-70 [Erratum, Clin Infect Dis 1997;25(2):352]
3. Schacker T, Collier AC, Hughes J, et al. Clinical and epidemiologic features of primary HIV infection. Ann Intern Med 1996; 125(4):257-64 [Erratum, Ann Intern Med 1997;126(2):174]
4. Bollinger RC, Brookmeyer RS, Mehendale SM, et al. Risk factors and clinical presentation of acute primary HIV infection in India. JAMA 1997;278(23):2085-9
5. Niu MT, Bethel J, Holodniy M, et al, and the DATRI 001 Study Group. Zidovudine treatment in patients with primary (acute) human immunodeficiency virus type 1 infection: a randomized, double-blind, placebo-controlled trial. J Infect Dis 1998; 178(1):80-91
6. Rich JD, Merriman NA, Mylonakis E, et al. Misdiagnosis of HIV infection by HIV-1 plasma viral load testing: a case series. Ann Intern Med 1999;130(1):37-9
7. Jacquez JA, Koopman JS, Simon CP, et al. Role of the primary infection in epidemics of HIV infection in gay cohorts. J Acquir Immune Defic Syndr 1994;7(11):1169-84
8. Little SJ, Daar ES, D'Aquila RT, et al. Reduced antiretroviral drug susceptibility among patients with primary HIV infection. JAMA 1999;282(12):1142-9
9. Finzi D, Hermankova M, Pierson T, et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 1997;278(5341):1295-300
10. Borrow P, Lewicki H, Hahn BH, et al. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 1994;68(9):6103-10
11. Mellors JW, Kingsley LA, Rinaldo CR Jr, et al. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 1995;122(8):573-9
12. Musey L, Highes J, Schacker T, et al. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection. N Engl J Med 1997;337(18):1267-74
13. Rosenberg ES, Billingsley JM, Caliendo AM, et al. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science 1997;278(5342):1447-50
14. Rosenberg ES. Preserving HIV-1 specific T-cell help: will it prevent progression? (Session 90) Proceedings, 6th Conference on Retroviruses and Opportunistic Infections. Chicago: 1999 Jan 31-Feb 4. Available at: http://www.retroconference.org/99. Accessed 2000 Feb 22
15. Pitcher CJ, Quittner C, Peterson DM, et al. HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression. Nat Med 1999;5(5):518-25
16. Carpenter CC, Cooper DA, Fischl MA, et al. Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel. JAMA 2000;283(3):381-90
17. Kinloch-De Loes S, Hirschel BJ, Hoen B, et al. A controlled trial of zidovudine in primary human immunodeficiency virus infection. N Engl J Med 1995;333(7):408-13 [Erratum, N Engl J Med 1995;333(20):1367]
18. Dalod M, Harzic M, Pellegrin I, et al. Evolution of cytotoxic T lymphocyte responses to human immunodeficiency virus type 1 in patients with symptomatic primary infection receiving antiretroviral triple therapy. J Infect Dis 1998;178(1):61-9
19. Lisziewicz J, Rosenberg E, Lieberman J, et al. Control of HIV despite the discontinuation of antiretroviral therapy. (Letter) N Engl J Med 1999;340(21):1682-4
20. Daar ES, Bai J, Hausner MA, et al. Acute HIV syndrome following discontinuation of antiretroviral therapy in a patient treated before seroconversion. Ann Intern Med 1998;128(10):827-9